JNJ - Emergent J&J resolve dispute over COVID vaccine manufacturing deal
2024-07-09 06:00:29 ET
Emergent BioSolutions ( NYSE: EBS ) and Johnson & Johnson ( NYSE: JNJ ) have reached a settlement agreement to resolve all claims related to a now-terminated manufacturing services deal for the latter's COVID-19 vaccine....
Emergent, J&J resolve dispute over COVID vaccine manufacturing deal